Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
Bacillus Calmette-Guerin (BCG) immunotherapy (i.e., intravesical instillation of live attenuated strain of Mycobacterium bovis) is a standard of care for non-muscle-invasive bladder cancer (NMIBC). The risk of infective adverse events is generally low as studies have reported an incidence of systemi...
Main Authors: | Stefania Arsuffi, Anna Cambianica, Elisa Di Filippo, Diego Ripamonti, Alessandra Tebaldi, Marco Enrico Giovanni Arosio, Claudio Francesco Farina, Marco Rizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579423000165 |
Similar Items
-
Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01) -
Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma
by: Aman Wadhwani, et al.
Published: (2018-08-01) -
A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01) -
Culture-proven disseminated Mycobacterium Bovis infection (BCG-Osis) following intravesical BCG immunotherapy in a patient with bladder carcinoma-in-situ: ‘Case report’
by: Ahmed Ghonaimy, et al.
Published: (2022-02-01) -
Extracellular forms of Mycobacterium bovis BCG in the mucosal lymphatic tissues following oral vaccination
by: Wenzel Czepluch, et al.
Published: (2013-01-01)